Shexiang Baoxin Pill Alleviates the Atherosclerotic Lesions in Mice via Improving Inflammation Response and Inhibiting Lipid Accumulation in the Arterial Wall

Epidemiological studies have demonstrated that cardiovascular diseases (CVDs) are the leading cause of death in the world. Atherosclerosis, a kind of chronic vascular disorder related to multiple pathogenic processes, has been reported to be an underlying cause of CVDs. Shexiang Baoxin Pill (SBP) is...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Li, Qin, Yating, Zhang, Xinxin, Chen, Chen, Xu, Xiangyu, Yu, Chingwen, Guo, Xiaomei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657610/
https://www.ncbi.nlm.nih.gov/pubmed/31379468
http://dx.doi.org/10.1155/2019/6710759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657610/
https://www.ncbi.nlm.nih.gov/pubmed/31379468
http://dx.doi.org/10.1155/2019/6710759

Ejemplares similares